Dec 15, 2015 · As a result, the approach has been rolled out across all of the studies conducted by CRUK’s Centre for Drug Development (CDD). Amgen started to implement RBM in 2012, according to Keri Aitchison, director of the company’s global development operations.

View the profiles of people named Keri Aitchison. Join Facebook to connect with Keri Aitchison and others you may know. Facebook gives people the power...

Check out professional insights posted by Keri Aitchison, Vice President, Head Clinical Trial Management & UK Site Head at Regeneron Pharmaceuticals, Inc.

We’re presenting positive Phase 2 data from our investigational bispecific antibody in relapsed/refractory #DLBCL during an oral session at #ASH22. Come join us, be part of an awesome team, grow...

View Keri Aitchison's email address (k*****@regene***.com) and phone number. Keri works at Regeneron Pharmaceuticals, Inc. as Vice President, Head Clinical Trial Mgmt & UK Site Head. Keri is based out of Guildford, England, United Kingdom and works in the Biotechnology Research industry.

25 Followers, 57 Following, 6 Posts - See Instagram photos and videos from Keri Aitchison (@keriaitchison)

Keri A. Aitchison's 3 research works with 121 citations and 25 reads, including: Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart ...

View FREE Public Profile & Reputation for Kerri Aitchison in Scottsdale, AZ - Court Records | Photos | Address, Email & Phone | Reviews | Net Worth

We’re presenting positive Phase 2 data from our investigational bispecific antibody in relapsed/refractory #DLBCL during an oral session at #ASH22. Come join us, be part of an awesome team, grow...